XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION PLANS (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of stock-based compensation expense
The following is a summary of stock-based compensation expense (benefit):
Three Months Ended September 30,Nine Months Ended September 30,
(dollars in thousands)2023202220232022
Restricted stock units$313 $230 $907 $1,072 
Performance restricted stock units295 119 652 530 
Total awards classified as equity608 349 1,559 1,602 
Stock appreciation rights51 (43)35 
Total stock-based compensation expense$611 $400 $1,516 $1,637 
Schedule of the summary of outstanding restricted stock units
The following is a summary of restricted stock unit activity:
Three Months Ended September 30,
20232022
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
Beginning balance129,422$19.58 120,631$17.98 
Granted
Vested
Forfeited(520)21.23(1,328)18.35
Ending balance128,902$19.57 119,303$17.98 
Nine Months Ended September 30,
20232022
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
Beginning balance139,986$18.01 109,244$17.27 
Granted41,84722.7246,31219.11
Vested(51,693)17.91(34,925)17.26
Forfeited(1,238)18.53(1,328)18.35
Ending balance128,902$19.57 119,303$17.98 
The following is a summary of performance restricted stock unit activity:
Three Months Ended September 30,
20232022
Performance
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
Performance
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
Beginning balance79,097$18.25 62,067$17.02 
Granted— — 
Vested— — 
Forfeited— — 
Ending balance79,097$18.25 62,067$17.02 
Nine Months Ended September 30,
20232022
Performance
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
Performance
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
Beginning balance62,067$17.02 38,344$15.72 
Granted17,03022.72 23,72319.14 
Vested— — 
Forfeited— — 
Ending balance79,097$18.25 62,067$17.02 
Schedule of the status of stock appreciation rights and changes
The following is a summary of stock appreciation rights activity:
Three Months Ended September 30,
20232022
Stock
Appreciation
Rights
Outstanding
Weighted
Average
Grant Date
Assigned Value
Stock
Appreciation
Rights
Outstanding
Weighted
Average
Grant Date
Assigned Value
Beginning balance73,440$16.32 91,800$16.32 
Granted— — 
Exercised— — 
Expired— — 
Forfeited— — 
Ending balance73,440$16.32 91,800$16.32 
Nine Months Ended September 30,
20232022
Stock
Appreciation
Rights
Weighted
Average
Grant Date
Assigned Value
Stock
Appreciation
Rights
Weighted
Average
Grant Date
Assigned Value
Beginning balance73,440$16.32 97,920$16.32 
Granted— — 
Exercised— (6,120)16.32 
Expired— — 
Forfeited— — 
Ending balance73,440$16.32 91,800$16.32 
A further summary of stock appreciation rights as of September 30, 2023, is as follows:
Stock Appreciation RightsWeighted Average
Remaining
Contractual Term
Grant Date Assigned ValuesOutstandingExercisable
$16.3273,44073,4405.9 years
Schedule of assumptions used in valuing stock appreciation rights The Company uses an option pricing model to value the stock appreciation rights, using the assumptions in the following table. Expected volatility is derived from the historical volatility of the Company’s stock price and a selected peer group of industry-related companies.
September 30, 2023December 31, 2022
Risk-free interest rate4.60 %3.95 %
Expected volatility37.29 %36.54 %
Expected life (in years)5.96.7
Expected dividend yield3.73 %3.27 %